- Home
- RADX vs ZCMD Comparison
RADX vs ZCMD Comparison
Compare RADX & ZCMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RADX
- ZCMD
- Stock Information
- Founded
- RADX 2021
- ZCMD 2012
- Country
- RADX Australia
- ZCMD China
- Employees
- RADX N/A
- ZCMD N/A
- Industry
- RADX
- ZCMD Other Consumer Services
- Sector
- RADX
- ZCMD Real Estate
- Exchange
- RADX NYSE
- ZCMD Nasdaq
- Market Cap
- RADX 32.5M
- ZCMD 28.5M
- IPO Year
- RADX N/A
- ZCMD 2020
- Fundamental
- Price
- RADX $4.81
- ZCMD $1.01
- Analyst Decision
- RADX Strong Buy
- ZCMD
- Analyst Count
- RADX 3
- ZCMD 0
- Target Price
- RADX $15.00
- ZCMD N/A
- AVG Volume (30 Days)
- RADX 18.6K
- ZCMD 44.3K
- Earning Date
- RADX 02-26-2025
- ZCMD 01-01-0001
- Dividend Yield
- RADX N/A
- ZCMD N/A
- EPS Growth
- RADX N/A
- ZCMD N/A
- EPS
- RADX N/A
- ZCMD N/A
- Revenue
- RADX $204,609.00
- ZCMD $15,864,773.00
- Revenue This Year
- RADX N/A
- ZCMD N/A
- Revenue Next Year
- RADX N/A
- ZCMD N/A
- P/E Ratio
- RADX N/A
- ZCMD N/A
- Revenue Growth
- RADX N/A
- ZCMD N/A
- 52 Week Low
- RADX $3.50
- ZCMD $0.95
- 52 Week High
- RADX $50.82
- ZCMD $2.97
- Technical
- Relative Strength Index (RSI)
- RADX N/A
- ZCMD 39.56
- Support Level
- RADX N/A
- ZCMD $1.02
- Resistance Level
- RADX N/A
- ZCMD $1.24
- Average True Range (ATR)
- RADX 0.00
- ZCMD 0.07
- MACD
- RADX 0.00
- ZCMD -0.01
- Stochastic Oscillator
- RADX 0.00
- ZCMD 0.00
About RADX RADIOPHARM THERANOSTICS LIMITED SPON ADS EACH REP 300 ORD
Radiopharm Theranostics Ltd is an Australian based clinical-stage radiotherapeutics company which is targeting cancer. The company has a pipeline of around four licensed platform technologies, with diagnostic and therapeutic applications in both pre-clinical and clinical stages of development. The company is engaged in research, development and commercialization of health technologies.
About ZCMD Zhongchao Inc.
ZHONGCHAO Inc is an offshore holding company incorporated in the Cayman Islands. Through its subsidiaries, it is a platform-based internet technology company offering services to patients with oncology and other diseases in China. It provide the healthcare information, education, and training services to the healthcare professionals under their MDMOOC brand. It also provide focused patient management services, through Zhongxun IT system and WeChat mini program and Zhongxin Health WeChat mini program, to pharmaceutical enterprises and NFP customers.